Cancer-related fatigue in patients with and survivors of Hodgkin's lymphoma: a longitudinal study of the German Hodgkin Study Group (Q39405959)

11 September 2017

Cancer-related fatigue in patients with and survivors of Hodgkin's lymphoma: a longitudinal study of the German Hodgkin Study Group (English)

1 reference

German Hodgkin Study Group

11 September 2017

17

object named as

German Hodgkin Study Group

1 reference

11 September 2017

Stefanie Kreissl

1

1 reference

11 September 2017

Horst Mueller

2

1 reference

11 September 2017

Helen Goergen

3

1 reference

11 September 2017

Axel Mayer

4

1 reference

11 September 2017

Corinne Brillant

5

1 reference

11 September 2017

Karolin Behringer

6

1 reference

11 September 2017

Teresa Veronika Halbsguth

7

1 reference

11 September 2017

Felicitas Hitz

8

1 reference

11 September 2017

Martin Soekler

9

1 reference

11 September 2017

Oluwatoyin Shonukan

10

1 reference

11 September 2017

Jens Ulrich Rueffer

11

1 reference

11 September 2017

Hans-Henning Flechtner

12

1 reference

11 September 2017

Michael Fuchs

13

1 reference

11 September 2017

Volker Diehl

14

1 reference

11 September 2017

Andreas Engert

15

1 reference

11 September 2017

Peter Borchmann

16

1 reference

11 September 2017

6 September 2016

1 reference

Lancet Oncology Commission

11 September 2017

1 reference

11 September 2017

17

1 reference

11 September 2017

10

1 reference

11 September 2017

1453-1462

1 reference

Hodgkin's disease survivors more fatigued than the general population.

11 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930093-6

7 January 2021

Health status and quality of life in patients with early-stage Hodgkin's disease treated on Southwest Oncology Group Study 9133.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930093-6

7 January 2021

Reduced health-related quality of life among Hodgkin's disease survivors: a comparative study with general population norms

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930093-6

7 January 2021

Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930093-6

7 January 2021

Fatigue in long-term survivors of Hodgkin‘s lymphoma; a report from the German Hodgkin Lymphoma Study Group (GHSG)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930093-6

7 January 2021

Dose-Intensification in Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD14 Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930093-6

7 January 2021

Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930093-6

7 January 2021

Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930093-6

7 January 2021

Second cancer risk after chemotherapy for Hodgkin's lymphoma: a collaborative British cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930093-6

7 January 2021

Late cardiotoxicity after treatment for Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930093-6

7 January 2021

Myocardial Infarction Mortality Risk After Treatment for Hodgkin Disease: A Collaborative British Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930093-6

7 January 2021

Persisting fatigue in Hodgkin lymphoma survivors: a systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930093-6

7 January 2021

Quality of life assessment in Hodgkin's disease: a new comprehensive approach. First experiences from the EORTC/GELA and GHSG trials. EORTC Lymphoma Cooperative Group. Groupe D'Etude des Lymphomes de L'Adulte and German Hodgkin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930093-6

7 January 2021

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930093-6

7 January 2021

Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930093-6

7 January 2021

A systematic review of the scales used for the measurement of cancer-related fatigue (CRF).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930093-6

7 January 2021

Quality, interpretation and presentation of European Organisation for Research and Treatment of Cancer quality of life questionnaire core 30 data in randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930093-6

7 January 2021

Implementing a system of quality-of-life diagnosis and therapy for breast cancer patients: results of an exploratory trial as a prerequisite for a subsequent RCT.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930093-6

7 January 2021

Using reference data on quality of life--the importance of adjusting for age and gender, exemplified by the EORTC QLQ-C30 (+3).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930093-6

7 January 2021

Latent growth curves within developmental structural equation models

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930093-6

7 January 2021

Fatigue in long-term Hodgkin's Disease survivors: a follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930093-6

7 January 2021

Quality of life in long-term Hodgkin's disease survivors with chronic fatigue.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930093-6

7 January 2021

Quality of life and psychological well-being in Spanish long-term survivors of Hodgkin's disease: results of a controlled pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930093-6

7 January 2021

Chronic fatigue in Hodgkin lymphoma survivors and associations with anxiety, depression and comorbidity

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930093-6

7 January 2021

10.1016/S1470-2045(16)30093-6

Identifiers

DOI

1 reference

11 September 2017

1 reference